Q2 2021 Holdings
Filed 2021-08-12 | 11 holdings | $15.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc.(CRNX) | Common Stock | 22663K107 | $15.5M | 820,720 | 98.2% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $82.3K | 508,558 | 0.5% |
| Passage Bio, Inc. | Common Stock | 702712100 | $65.7K | 4,959,769 | 0.4% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $47.3K | 2,320,381 | 0.3% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $40.6K | 4,450,638 | 0.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $17.7K | 5,068,233 | 0.1% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $15.3K | 617,727 | 0.1% |
| Flexion Therapeutics, Inc. | Common Stock | 33938J106 | $8.2K | 1,000,000 | 0.1% |
| Aprea Therapeutics, Inc | Common Stock | 03836J102 | $6.1K | 1,259,662 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $2.4K | 543,753 | 0.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $591 | 101,855 | 0.0% |